FR2814M - Médicament a base de δ<4>-prégnene-14.15-époxy-17α.21-diol-3.20-dione et de ses 21-esters. - Google Patents

Médicament a base de δ<4>-prégnene-14.15-époxy-17α.21-diol-3.20-dione et de ses 21-esters.

Info

Publication number
FR2814M
FR2814M FR938129A FR938129A FR2814M FR 2814 M FR2814 M FR 2814M FR 938129 A FR938129 A FR 938129A FR 938129 A FR938129 A FR 938129A FR 2814 M FR2814 M FR 2814M
Authority
FR
France
Prior art keywords
pregnene
dione
diol
esters
epoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR938129A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to FR938129A priority Critical patent/FR2814M/fr
Application granted granted Critical
Publication of FR2814M publication Critical patent/FR2814M/fr
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR938129A 1963-06-14 1963-06-14 Médicament a base de δ<4>-prégnene-14.15-époxy-17α.21-diol-3.20-dione et de ses 21-esters. Active FR2814M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR938129A FR2814M (fr) 1963-06-14 1963-06-14 Médicament a base de δ<4>-prégnene-14.15-époxy-17α.21-diol-3.20-dione et de ses 21-esters.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR938129A FR2814M (fr) 1963-06-14 1963-06-14 Médicament a base de δ<4>-prégnene-14.15-époxy-17α.21-diol-3.20-dione et de ses 21-esters.

Publications (1)

Publication Number Publication Date
FR2814M true FR2814M (fr) 1964-09-28

Family

ID=86605598

Family Applications (1)

Application Number Title Priority Date Filing Date
FR938129A Active FR2814M (fr) 1963-06-14 1963-06-14 Médicament a base de δ<4>-prégnene-14.15-époxy-17α.21-diol-3.20-dione et de ses 21-esters.

Country Status (1)

Country Link
FR (1) FR2814M (fr)

Similar Documents

Publication Publication Date Title
FR1916M (fr) Médicament a base de 16.α-méthyl-6-α-fluoro-1.4-prégnadiene-11.β.21-diol-3.20-dione.
FR3821M (fr) Médicament anti-inflammatoire a base de 17,21-orthoester de stéroide.
FR1996M (fr) Stéroides de la série de l&#39;oestrane.
FR1084M (fr) Médicament a propriétés anti-inflammatoires.
FR2476M (fr) Nouveaux stéroides de la série de l&#39;androstane.
FR3251M (fr) Nouveaux médicaments dérivés de l&#39;androstane et de l&#39;androstene.
CA660637A (en) 9.alpha.-HALO STEROIDS AND PROCESS
CA662635A (en) 16.alpha.-METHYL-17.alpha.-HYDROXY-COMPOUNDS OF THE ALLOPREGNANE SERIES AND PROCESS FOR THEIR MANUFACTURE
CA705429A (en) 6.alpha.-METHYL-11-OXYGENATED-.DELTA.4-PREGNENE-17.alpha.,21-DIOL-3,20-DIONE AND ITS ESTERS
CA661389A (en) 6.alpha.: 16-DIMETHYLPREGNA-4:16-DIEN-3:20-DIONE AND PROCESS FOR ITS PREPARATION
CA718007A (en) 4,4,14-trimethyl steroids of the pregnane series
AU286605B2 (en) 19-nor-4,9,11-pregnatriene-3,20-dione, process and intermediates
CA762440A (en) 6.alpha.-FLUOROMETHYL STEROIDS OF THE PREGNANE SERIES
CA701108A (en) 1,4,6-PREGNATRIENE-11.beta.,17.alpha.,21-DIOL-3,20-DIONE AND 21-ESTERS
CA740875A (en) 9-halo-4-pregnene-16,17,21-triol-3,11,20-trione and its 16,21-esters
FR3624M (fr) Glycuronides et galacturonides de stéroides.
CA662633A (en) 16.alpha.-METHYL-ALLOPREGNANES SUBSTITUTED IN THE 21-POSITION AND PROCESS FOR THEIR MANUFACTURE
AU294436B2 (en) 2, 3-epithio steroids ofthe androstane series
CA754554A (en) 16.alpha.-FLUOROMETHYL CORTICO STEROIDS OF THE PREGNANE SERIES AND PROCESS
FR1364261A (fr) 11, 17alpha, 21-trihydroxy-9beta, 10alpha-pregn-4-ène-3, 20-dione et sa preparation
CA671461A (en) Photoelastic devices and methods for the manufacture thereof
AU414579B2 (en) 17x-alka-1&#39; 3&#39;dinyl steroids
CA737450A (en) 16.alpha.-ALKYL-17.alpha.,21-DIHYDROXY-4-PREGNENE-3,20-DIONE 21-ACYLATE
CA674012A (en) Flexible tubes and the manufacture thereof
CA779285A (en) 1,2.alpha.-METHYLENE STEROIDS OF THE PREGNANE SERIES AND PROCESS FOR THEIR MANUFACTURE